1. Intracellular metabolism and in vitro activity of TDF against hepatitis B virus;Delaney WE, Ray AS, Yang H, Qi X, Xiong S, Zhu Y, Miller MD;Antimicrobial Agents and Chemotherapy,2006
2. Is TDF alafenamide safer than TDF disoproxil fumarate for the kidneys?;Aloy B, Tazi I, Bagnis CI, Gauthier M, Janus N, LaunayVacher V, Deray G, Tourret J;AIDS Rev,2016
3. TDF disoproxil fumarate;Kearney BP, Flaherty JF, Shah J;Clinical Pharmacokinetics,2004
4. Pharmacokinetics and dosing recommendations of TDF disoproxil fumarate in hepatic or renal impairment;Kearney BP, Yale K, Shah J, Zhong L, Flaherty JF;Clinical Pharmacokinetics,2006
5. TDF nephrotoxicity: 2011 update.;Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-NinoMD,IzquierdoMC,PovedaJ,Sainz-PrestelV, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, Ruiz-Ortega M;AIDS Research and Treatment,2011